Pulse Canada   Report issue

Academic/Hospital Phase 2
Founded: Winnipeg Canada (1997)

Organization Overview

First Clinical Trial
2008
NCT00877968
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Pulse Canada

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypercholesterolemia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 11